Clinical and In vitro Data Shed New Light on the Therapeutic Advantages of Black Seeds (Nigella sativa) for the Treatment of Hepatitis C and Hepatitis B Viral Infections
Patients with HCV and HBV infections may benefit from using black seeds (N. sativa) as an adjuvant therapy in addition to conventional therapy. Additional randomized controlled clinical trials would confirm the safety and effectiveness of Nigella sativa (black seeds) in treating HCV and HBV infections.
Authors
- Rajkapoor Balasubramanian (ORCID: https://orcid.org/0000-0002-1125-7800)
- Mansoor Hameed (ORCID: https://orcid.org/0000-0002-2341-7883)
- Naina Mohamed Pakkir Maideen (ORCID: https://orcid.org/0000-0002-6950-9783)
- Ramalingam Senthil (ORCID: https://orcid.org/0000-0001-7570-8351)
- Mohamed Harsath Jahir Hussain
- Kumar Balasubramanian (ORCID: https://orcid.org/0009-0002-2569-6721)
Institutions
- Dubai Health Authority (AE)
- Shri Venkateshwara University (IN)
- Pondicherry Institute of Medical Sciences (IN)
- Indira Gandhi Medical College and Research Institute (IN)
- Gokula Krishna College of Pharmacy (IN)
- Mahatma Gandhi Medical College and Research Institute (IN)
- Gandhi Medical College (IN)
- Medical Research Foundation (GB)
- Institute of Medical Sciences (IN)
Publication Details
- Journal
- Infectious Disorders - Drug Targets
- Published
- 2025-02-21
- DOI
- https://doi.org/10.2174/0118715265331112250115061024
- Primary Topic
- Nigella sativa pharmacological applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00